Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer. 2024 May;202:114037. doi: 10.1016/j.ejca.2024.114037. Epub 2024 Mar 26.
Eur J Cancer. 2024.
PMID: 38554542
Free article.
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy.
Roussot N, Vincent J, Palmier R, Constantin G, Bengrine L, Fumet JD, Ghiringhelli F.
Roussot N, et al.
Front Oncol. 2023 Nov 30;13:1293670. doi: 10.3389/fonc.2023.1293670. eCollection 2023.
Front Oncol. 2023.
PMID: 38098503
Free PMC article.
Item in Clipboard
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
Roussot N, Fumet JD, Limagne E, Thibaudin M, Hervieu A, Hennequin A, Zanetta S, Dalens L, Fourrier T, Galland L, Jacob P, Bertaut A, Rederstorff E, Chevalier C, Ghirardi S, Gilbert E, Khoukaz A, Martin E, Nicolet C, Quivrin M, Thibouw D, Vulquin N, Truc G, Rouffiac M, Ghiringhelli F, Mirjolet C.
Roussot N, et al.
BMC Cancer. 2023 Nov 9;23(1):1080. doi: 10.1186/s12885-023-11534-6.
BMC Cancer. 2023.
PMID: 37946136
Free PMC article.
Clinical Trial.
Item in Clipboard
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report.
Roussot N, Lecuelle J, Dalens L, Truntzer C, Ghiringhelli F.
Roussot N, et al.
J Immunother Cancer. 2023 Oct;11(10):e007763. doi: 10.1136/jitc-2023-007763.
J Immunother Cancer. 2023.
PMID: 37890888
Free PMC article.
Item in Clipboard
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Ilie SM, Briot N, Constantin G, Roussot N, Ilie A, Bergeron A, Arnould L, Beltjens F, Desmoulin I, Mayeur D, Kaderbhai C, Hennequin A, Jankowski C, Padeano MM, Costaz H, Amet A, Coutant C, Coudert B, Bertaut A, Ladoire S.
Ilie SM, et al. Among authors: roussot n.
Breast Cancer. 2023 Nov;30(6):997-1007. doi: 10.1007/s12282-023-01490-1. Epub 2023 Aug 10.
Breast Cancer. 2023.
PMID: 37561255
Free PMC article.
Item in Clipboard
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Galland L, Roussot N, Desmoulins I, Mayeur D, Kaderbhai C, Ilie S, Hennequin A, Reda M, Albuisson J, Arnould L, Boidot R, Truntzer C, Ghiringhelli F, Ladoire S.
Galland L, et al. Among authors: roussot n.
Cancers (Basel). 2023 Feb 18;15(4):1299. doi: 10.3390/cancers15041299.
Cancers (Basel). 2023.
PMID: 36831640
Free PMC article.
Review.
Item in Clipboard
Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment.
Roussot N, Ghiringhelli F, Rébé C.
Roussot N, et al.
Cells. 2022 Nov 18;11(22):3672. doi: 10.3390/cells11223672.
Cells. 2022.
PMID: 36429101
Free PMC article.
Review.
Item in Clipboard
Cite
Cite